| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages
|
Edwards, Christopher R.
|
|
|
127 |
17 |
p. e24-e34
|
artikel
|
| 2 |
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
|
Nadeu, Ferran
|
|
|
127 |
17 |
p. 2122-2130
|
artikel
|
| 3 |
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
|
Möricke, Anja
|
|
|
127 |
17 |
p. 2101-2112
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
127 |
17 |
p. i
|
artikel
|
| 5 |
Follicular lymphoma: evolving therapeutic strategies
|
Kahl, Brad S.
|
|
|
127 |
17 |
p. 2055-2063
|
artikel
|
| 6 |
Glucocorticoid selection for pediatric ALL
|
Hunger, Stephen P.
|
|
|
127 |
17 |
p. 2049-2051
|
artikel
|
| 7 |
HLH susceptibility: genetic lesions add up
|
Meeths, Marie
|
|
|
127 |
17 |
p. 2051-2052
|
artikel
|
| 8 |
Introduction to a review series: the paradox of indolent B-cell lymphoma
|
Sehn, Laurie H.
|
|
|
127 |
17 |
p. 2045-2046
|
artikel
|
| 9 |
Mannick JA, Lochte HL Jr, Ashley CA, Thomas ED, Ferrebee JW. Autografts of bone marrow in dogs after lethal total-body radiation. Blood. 1960;15(2): 255-266.
|
|
|
|
127 |
17 |
p. 2047
|
artikel
|
| 10 |
Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases
|
Dasgupta, Yashodhara
|
|
|
127 |
17 |
p. 2131-2143
|
artikel
|
| 11 |
Not all subclones matter in CLL
|
Sutton, Lesley-Ann
|
|
|
127 |
17 |
p. 2052-2054
|
artikel
|
| 12 |
Optimizing therapy for nodal marginal zone lymphoma
|
Thieblemont, Catherine
|
|
|
127 |
17 |
p. 2064-2071
|
artikel
|
| 13 |
Peripheral blood findings in GM1 gangliosidosis
|
Lynch, David T.
|
|
|
127 |
17 |
p. 2161
|
artikel
|
| 14 |
Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice
|
Sepulveda, Fernando E.
|
|
|
127 |
17 |
p. 2113-2121
|
artikel
|
| 15 |
Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition
|
Raab, Marc S.
|
|
|
127 |
17 |
p. 2155-2157
|
artikel
|
| 16 |
Splenic marginal zone lymphoma: from genetics to management
|
Arcaini, Luca
|
|
|
127 |
17 |
p. 2072-2081
|
artikel
|
| 17 |
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
|
Flynn, Ryan
|
|
|
127 |
17 |
p. 2144-2154
|
artikel
|
| 18 |
The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia
|
Olombel, Guillaume
|
|
|
127 |
17 |
p. 2157-2160
|
artikel
|
| 19 |
The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma
|
Kuruvilla, John
|
|
|
127 |
17 |
p. 2093-2100
|
artikel
|
| 20 |
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
|
Zucca, Emanuele
|
|
|
127 |
17 |
p. 2082-2092
|
artikel
|
Tijdschrift beschrijving